Sfoglia per Rivista CANCER RESEARCH
The seco-taxane IDN5390 is able to target class III beta-tubulin and to overcome paclitaxel resistance
2005-01-01 Ferlini, C.; Raspaglio, G.; Mozzetti, S.; Cicchillitti, L.; Filippetti, F.; Gallo, D.; Fattorusso, C.; Campiani, G.; Scambia, G.
STING activation reverses lymphoma-mediated resistance to antibody immunotherapy
2017-01-01 Dahal, Lekh N; Dou, Lang; Hussain, Khiyam; Liu, Rena; Earley, Alexander; Cox, Kerry L; Murinello, Salome; Tracy, Ian; Forconi, Francesco; Steele, Andrew J; Duriez, Patrick; Gomez Nicola, Diego; Teeling, Jessica L; Glennie, Martin J; Cragg, Mark S; Beers, Stephen A.
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity
2013-01-01 Bracci, Luisa; Falciani, Chiara; Brunetti, Jlenia; Lelli, Barbara; Ravenni, Niccolo; Lozzi, Luisa; Depau, Lorenzo; Pini, Alessandro
VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression
2004-01-01 Woolard, J.; Wang, W. Y.; Bevan, H. S.; Qiu, Y.; Morbidelli, Lucia; Pritchard, Jones; R., O.; Cui, T. G.; Sugiono, M.; Waine, E.; Perrin, R.; Foster, R.; Digby Bell, J.; Shields, J. D.; Whittles, C. E.; Mushens, R. E.; Gillatt, D. A.; Ziche, Marina; Harper, S. J.; Bates, D. O.
Who is the boss in the Retinoblastoma family? The point of view of Rb2/p130, the little brother
2001-01-01 Paggi, M. G.; Giordano, A.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| The seco-taxane IDN5390 is able to target class III beta-tubulin and to overcome paclitaxel resistance | 1-gen-2005 | Ferlini, C.; Raspaglio, G.; Mozzetti, S.; Cicchillitti, L.; Filippetti, F.; Gallo, D.; Fattorusso, C.; Campiani, G.; Scambia, G. | - | |
| STING activation reverses lymphoma-mediated resistance to antibody immunotherapy | 1-gen-2017 | Dahal, Lekh N; Dou, Lang; Hussain, Khiyam; Liu, Rena; Earley, Alexander; Cox, Kerry L; Murinello, Salome; Tracy, Ian; Forconi, Francesco; Steele, Andrew J; Duriez, Patrick; Gomez Nicola, Diego; Teeling, Jessica L; Glennie, Martin J; Cragg, Mark S; Beers, Stephen A. | - | |
| Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity | 1-gen-2013 | Bracci, Luisa; Falciani, Chiara; Brunetti, Jlenia; Lelli, Barbara; Ravenni, Niccolo; Lozzi, Luisa; Depau, Lorenzo; Pini, Alessandro | - | |
| VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression | 1-gen-2004 | Woolard, J.; Wang, W. Y.; Bevan, H. S.; Qiu, Y.; Morbidelli, Lucia; Pritchard, Jones; R., O.; Cui, T. G.; Sugiono, M.; Waine, E.; Perrin, R.; Foster, R.; Digby Bell, J.; Shields, J. D.; Whittles, C. E.; Mushens, R. E.; Gillatt, D. A.; Ziche, Marina; Harper, S. J.; Bates, D. O. | - | |
| Who is the boss in the Retinoblastoma family? The point of view of Rb2/p130, the little brother | 1-gen-2001 | Paggi, M. G.; Giordano, A. | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile